Paper Talk podcast

1749-Molecular Mechanisms and Pathogenesis of MASH

08/11/2026
0:00
23:54
Reculer de 15 secondes
Avancer de 15 secondes

Metabolic dysfunction-associated steatotic liver disease (MASLD) and its advanced inflammatory stage, metabolic dysfunction-associated steatohepatitis (MASH), represent a major global health crisis closely linked to the obesity epidemic, poor diet, and sedentary lifestyles. The sources explain that the pathogenesis of MASH is a complex, multi-organ process driven by insulin resistance, adipose tissue dysfunction, genetic variants, endoplasmic reticulum and oxidative stress, and disruptions of the gut-liver and brain-liver axes. Furthermore, chronic inflammation involving both innate and adaptive immune responses, alongside cellular senescence and circadian rhythm misalignments, accelerates disease progression from simple steatosis to severe fibrosis, cirrhosis, and hepatocellular carcinoma. Because MASH exhibits substantial patient heterogeneity and functions as a systemic disease rather than a purely hepatic condition, researchers emphasize the necessity of personalized therapeutic strategies and multi-modal interventions to improve clinical outcomes.

References:

  • Gallage S, Govaere O, Anstee Q M, et al. Molecular mechanisms and pathogenesis of MASH[J]. Nature, 2026, 657(8130): 59-75.


前往小宇宙评论区与主播互动

D'autres épisodes de "Paper Talk"